Answers are grounded in this paper and cite their sources.
This review synthesizes the role of lactylation in regulatory networks, linking cellular metabolism to disease implications.
Lactate and lysine lactylation (Kla) have evolved from being viewed as metabolic end products to key molecular mediators linking cellular metabolism to chromatin dynamics and signaling outputs. Emerging evidence indicates that Kla participates in a highly coordinated network of post-translational modification (PTM) crosstalk, where lysine-specific competition, cooperation, and antagonism collectively shape cellular behavior across diverse pathologies-including cancer, infection, inflammation, hypoxia, and metabolic dysfunction. Here, we synthesize the mechanistic logic underlying Kla-centered PTM interplay, encompassing structural constraints from adjacent residue occupancy, competition or co-utilization of modifying enzyme systems, and integration of metabolic flux with epigenetic and transcriptional programs. We further map representative regulatory axes linking Kla with acetylation, phosphorylation, ubiquitination, methylation, and N⁶-methyladenosine (m⁶A) RNA modification, and propose models explaining context-dependent divergence in Kla's regulatory actions. At the chromatin level, Kla orchestrates inflammatory responses, enabling a coordinated shift from immune activation to tolerance and tissue repair. In non-histone substrates, Kla acts via two primary modes: modification-site-specific competition, and structural synergy. Kla additionally interfaces with RNA and signaling hierarchies, amplifying regulatory outputs through m⁶A machinery and pathways such as JAK-STAT. Its crosstalk with ubiquitination reshapes proteostasis, driving key pathological processes including anticancer drug resistance, fibrotic, cardiovascular injury, and sepsis. We also highlight critical field barriers, including quantitative site-resolved detection, enzyme specificity definition, and non-enzymatic D -lactylation characterization. Finally, we propose a roadmap for constructing integrated Kla-PTM regulatory frameworks at molecular, cellular, and systems levels. Such efforts will be essential for decoding metabolism-driven epigenetic control and for advancing therapeutic strategies that target lactate-responsive regulatory mechanisms in human disease.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: